CRUK Cambridge Centre: Urological Malignancies (@crukcamurol) 's Twitter Profile
CRUK Cambridge Centre: Urological Malignancies

@crukcamurol

Cancer Research UK Cambridge Centre Urological Malignancies Virtual Institute. World class, interdisciplinary research to combat urological cancers.

ID: 1024247083061202944

linkhttps://www.cambridge-urologicalmalignancies.org.uk/ calendar_today31-07-2018 10:55:08

416 Tweet

457 Followers

143 Following

BMJ Oncology (@bmjoncology) 's Twitter Profile Photo

There is very little evidence presented in guidelines that current recommendations for cancer recurrence surveillance improve patient outcomes. bmjoncology.bmj.com/content/4/1/e0…

There is very little evidence presented in guidelines that current recommendations for cancer recurrence surveillance improve patient outcomes. bmjoncology.bmj.com/content/4/1/e0…
CRUK Cambridge Centre: Urological Malignancies (@crukcamurol) 's Twitter Profile Photo

Meet Jenifer from Otley, West Yorkshire. Jenifer's kidney cancer was discovered during our kidney screening trial, YKST. Thanks to this study, funded by Yorkshire Cancer Research, Jenifer's cancer was treated early. Now she's getting back to line dancing 👢 yorkshirecancerresearch.org.uk/news/i-feel-so…

CRUK Cambridge Centre: Urological Malignancies (@crukcamurol) 's Twitter Profile Photo

Join us on Weds 23 April for breakfast and talks about future directions in kidney cancer research. Book your place: eventbrite.co.uk/e/breakfast-me…

Join us on Weds 23 April for breakfast and talks about future directions in kidney cancer research. Book your place: eventbrite.co.uk/e/breakfast-me…
CRUK Cambridge Centre (@crukcamcentre) 's Twitter Profile Photo

Using a machine learning model to analyse data from the NAXIVA trial, CRUK Cambridge Centre: Urological Malignancies members have discovered early markers of response in patients treated for kidney cancer with venous tumour thrombus using a drug called axitinib. Nature Communications Read more: crukcambridgecentre.org.uk/news/researche…

Using a machine learning model to analyse data from the NAXIVA trial, <a href="/CRUKCamUrol/">CRUK Cambridge Centre: Urological Malignancies</a> members have discovered early markers of response in patients treated for kidney cancer with venous tumour thrombus using a drug called axitinib. <a href="/NatureComms/">Nature Communications</a> 

Read more: crukcambridgecentre.org.uk/news/researche…